MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3899/jrheum.190313

Медицинская библиотека · The Journal of rheumatology · 2019

Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 Patients.

Lhote Raphael, Chilles Marie, Groh Matthieu, Puéchal Xavier, Guilpain Philippe, Ackermann Félix, Amoura Zahir, Annesi-Maesano Isabella, Barba Thomas, Catherinot Emilie, Cohen-Aubart Fleur, Cohen Pascal, Cottin Vincent, Couderc Louis-Jean, De Boysson Hubert, Delbrel Xavier, Dominique Stéphane, Duhaut Pierre, Fain Olivier, Hachulla Eric, Hamidou Mohamed, Kahn Jean-Emmanuel, Legendre Christophe, Le Quellec Alain, Lhote François, Lifermann François, Mathian Alexis, Néel Antoine, Nunes Hilario, Subra Jean-François, Terrier Benjamin, Mouthon Luc, Diot Elisabeth, Guillevin Loïc, Brillet Pierre-Yves, Tcherakian Colas, French Vasculitis Study Group (FVSG) and the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P)

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVE

To report on a large series of patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and bronchiectasis, with a specific focus on the timeline of occurrence of both features.

METHODS

Retrospective nationwide multicenter study of patients diagnosed with both AAV and bronchiectasis.

RESULTS

Sixty-one patients were included, among whom 27 (44.25%) had microscopic polyangiitis (MPA), 27 (44.25%) had granulomatosis with polyangiitis (GPA), and 7 (11.5%) had eosinophilic GPA. Thirty-nine (64%) had myeloperoxidase (MPO)-ANCA and 13 (21%) had proteinase 3-ANCA. The diagnosis of bronchiectasis either preceded (n = 25; median time between both diagnoses: 16 yrs, IQR 4-54 yrs), was concomitant to (n = 12), or followed (n = 24; median time between both diagnoses: 1, IQR 0-6 yrs) that of AAV. Patients in whom bronchiectasis precedes the onset of AAV (B-AAV group) have more frequent mononeuritis multiplex, MPA, MPO-ANCA, and a 5-fold increase of death. The occurrence of an AAV relapse tended to be protective against bronchiectasis worsening (HR 0.6, 95% CI 0.4-0.99, P = 0.049), while a diagnosis of bronchiectasis before AAV (HR 5.8, 95% CI 1.2-28.7, P = 0.03) or MPA (HR 18.1, 95% CI 2.2-146.3, P = 0.01) were associated with shorter survival during AAV follow-up.

CONCLUSION

The association of bronchiectasis with AAV is likely not accidental and is mostly associated with MPO-ANCA. Patients in whom bronchiectasis precedes the onset of AAV tend to have distinct clinical and biological features and could carry a worse prognosis.

Для цитирования: Lhote Raphael, Chilles Marie, Groh Matthieu, Puéchal Xavier, Guilpain Philippe, Ackermann Félix, Amoura Zahir, Annesi-Maesano Isabella, Barba Thomas, Catherinot Emilie, Cohen-Aubart Fleur, Cohen Pascal, Cottin Vincent, Couderc Louis-Jean, De Boysson Hubert, Delbrel Xavier, Dominique Stéphane, Duhaut Pierre, Fain Olivier, Hachulla Eric, Hamidou Mohamed, Kahn Jean-Emmanuel, Legendre Christophe, Le Quellec Alain, Lhote François, Lifermann François, Mathian Alexis, Néel Antoine, Nunes Hilario, Subra Jean-François, Terrier Benjamin, Mouthon Luc, Diot Elisabeth, Guillevin Loïc, Brillet Pierre-Yves, Tcherakian Colas, French Vasculitis Study Group (FVSG) and the Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P). Spectrum and Prognosis of Antineutrophil Cytoplasmic Antibody-associated Vasculitis-related Bronchiectasis: Data from 61 Patients.. The Journal of rheumatology. 2019. DOI: 10.3899/jrheum.190313.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.